Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States)

Cancer Causes and Control

Volumn 17, Issue 7, 2006, Pages 931-938

  Gebregziabher, Mulugeta ^a   Bernstein, Leslie ^a   Wang, Yaping ^a   Cozen, Wendy ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Epidemiology; Incidence rates; Multiple myeloma; Race; Socioeconomic status

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; ASIAN AMERICAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; EUROPEAN AMERICAN; FEMALE; FILIPINO; HIGH RISK POPULATION; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REGISTER; RELIGION; RISK ASSESSMENT; SOCIOECONOMICS; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LOS ANGELES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; RISK FACTORS; SEER PROGRAM; SEX DISTRIBUTION; SOCIAL CLASS;

EID: 33746092056     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-006-0030-x     Document Type: Article

References (44)

1. Morgan G, Davies F, Linet M (2002) Myeloma aetiology and epidemiology. Biomed Pharmacother 56:223-234
2. Kosmas C, Stamatopoulos K, Stavroyianni N, et al (2000) Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoire. Leukemia 14:1718-1726
3. Sirohi B, Powles R (2004) Multiple myeloma. Lancet 363:875-887
4. Herrinton L, Weiss N, Olshan A (1996) Multiple myeloma. In: Schottenfeld D, Fraumeni JJ (eds) Cancer epidemiology and prevention. Oxford University Press, New York, pp 946-970
5. Bergasel D (1995) The incidence and epidemiology of plasma cell neoplasms. Stem Cells 13(supplement 2):1-9
6. Miller B, Kolonel L, Bernstein L, et al (1996) Racial/ethnic patterns of cancer in the United States 1988-1992. National Cancer Institute, Bethesda, MD. NIH Pub. No. 96-4104
7. Koessel S, Theis M, Vaughan T, et al (1996) Socioeconomic status and the incidence of multiple myeloma. Epidemiology 7:1-3
8. Pasqualetti P, Casale R, Collacciani A, Colantonio D (1990) Work activities and the risk of multiple myeloma: a case-control study. Med Lav 81:308-319
9. Baris D, Brown L, Silverman D, et al (2000) Socioeconomic status and multiple myeloma among US blacks and whites. Am J Public Health 90(8):1277-1281
10. Johnston J, Grufferman S, Bourguet C, Delzell E, Delong E, Cohen H (1985) Socioeconomic status and risk of multiple myeloma. Epidemiol Commun Health J 39:175-178
11. Figgs L, Dosemeci M, Blair A (1994) Risk of multiple myeloma by occupation and industry among men and women: a 24-state death certificate study. J Occup Med 36:1210-1221
12. Mack T (1977) Cancer surveillance program in Los Angeles County. Nat Cancer Inst Monogr 47:99-101
13. Fritz A, Percy C, Jack A, et al (eds) (2000) International classification of diseases for oncology. 3rd edn. World Health Association, Geneva
14. Boyle P, Parkin D (1991) Statistical methods for registries. International Agency for Research on Cancer, Lyon, France
15. Liu L, Deapen D, Bernstein L (1998) Socioeconomic status and cancer of the female breast and reproductive organs: a comparison across racial/ethnic population in Los Angeles County, California (United states). Cancer Causes Controls 9:369-380
16. Riedel D, Pottern L (1992) The epidemiology of multiple myeloma. Hematol Oncol Clin N Am 6(2):225-247
17. Hernandez J, Land K, McKenna R (1995) Leukemias, myeloma and other lymphoreticular neoplasms. Cancer 75(1 Suppl):381-394
18. Walker B, Figgs L, Zahm S (1995) Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect 103(supplement 8):275-281
19. Benjamin M, Reddy S, Brawley O (2003) Myeloma and race: a review of the literature. Cancer Metastatsis Rev 22:87-93
20. Grulich A, Swerdlow A, Head J, Marmot M (1992) Cancer mortality in African and Caribbean migrants to England and Wales. Br J Cancer 66(5):905-911
21. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2002) Cancer in five continents; IARC Scientific Publications No. 155. International Agency for Research on Cancer, Lyon, France
22. Nossent J, Winkel C, van Leeuwen J (1993) Multiple myeloma in the Afro-Caribbean population of Curacao. Neth J Med 43(5-6):210-214
23. Besson C, Gonin C, Brebion A, Delaunay C, Panelatti G, Plumelle Y (2001) Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T cell leukemia/lymphoma. Leukemia 15:828-831
24. Cozen W, Katz J, Mack T (1992) Risk patterns of Hodgkin's disease in Los Angeles vary by cell type. Cancer Epidemiol Biomarkers Preven 1:261-268
25. Gale R, Cozen W, Goodman M, Wang F, Bernstein L (2000) Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County. Leuk Res 24:665-669
26. Mack T, Walker A, Mack W, Bernstein L (1985) Cancer in hispanics in Los Angeles County. Nat Cancer Inst Monogr 69:99-104
27. Shulman G, Jacobson R (1980) Immunocytoma in black and white South Africans. Trop Geogr Med 32(2):112-117
28. Devesa S, Silverman D, Young JJ, et al (1987) Cancer incidence and mortality trends among whites in the United States, 1947-84. JNCI 79(4):701-710
29. Boffetta P, Stellman S, Garfinkel L (1989) A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int J Cancer 43:554-559
30. Bernstein L, Newton P, Ross R (1889) Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res 50(12):3605-3609
31. Mack T, Berkel J, Bernstein L, Mack W (1985) Religion and cancer in Los Angeles County. Nat Cancer Inst Monogr 69:235-245
32. Kishimoto T (2003) Interleukin-6 (IL-6). In: Thomson A, Lotze M (eds) The cytokine handbook. Academic Press, London pp 281-304
33. Lauta V (2003) A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer 97(10):2440-2552
34. Michalaki V, Syrigos K, Charles P, Waxman J (2004) Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. BrJ Cancer 90(12):2312-2316
35. Martin A, Athanasiadis G, Greshock J, et al (2003) Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes. Human Hered 55:171-176
36. Delaney N, Esquenazi V, Lucas D, Zachary A, Leffell M (2004) TNF-alpha, TFG-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI minority workshops: Part IV. Human Immunol 65:1413-1419
37. Hoffmann S, Stanley E, Cox E, et al (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560-567
38. Lim C, Zheng S, Kim Y, et al (2002) The -174 G to C polymorphism of interleukin-6 gene is very rare in koreans. Cytokine 19:52-54
39. Zheng C, Huang D, Bergenbrant S, et al (2000) Interleukin 6, tumour necrosis factor [alpha], interleukin 1 [beta] and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol 109(1):39-45
40. Dring A, FE Davis, Rollinson S, et al (2001) Interleukin 6, tumour necrosis factor [alpha] and lymphotoxin [alpha] polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma. Br J Haematol 112(1):249-250
41. Iakupova E, Grinchuk O, Kalimullina D, et al (2003) Molecular genetic analysis of the interleukin 6 and tumor necrosis factor alpha gene polymorphisms in multiple myeloma. Mol Biol 37(3):420-424
42. Mazur G, Bogunia-Kubik K, Wrobel T, et al (2005) IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma. Immunol Lett 96:241-246
43. Peng B, Hodge D, Thomas S, et al (2005) Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells. J Biol Chem 280(6):4182-4187
44. Velangi M, Matheson E, Morgan G, et al (2004) DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma. Carcinogenesis 25(10):1795-1803